Research ArticleCancer Drug Development

Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors

Science Translational Medicine  04 Aug 2010:
Vol. 2, Issue 43, pp. 43ra55
DOI: 10.1126/scitranslmed.3001065

Log in to view the full text

Navigate This Article

  1. Article
    1. Abstract
    2. Introduction
    3. Results
    4. Discussion
    5. Materials and Methods
    6. Supplementary Material
    7. Footnotes
    8. References and Notes
  2. Figures & Data
  3. Info & Metrics
  4. eLetters
  5. PDF